Predictors of heart failure with reduced or mildly reduced ejection fraction development in hypertrophic cardiomyopathy: a single-centre study

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

About the speaker

Doctor Helena Santos Moreira

Sao Joao University Hospital Centre, Porto (Portugal)

5 More presentations in this session

Presentation thumbnail

Predictive accuracy of the H2FPEF score in patients with and without lung disease

Doctor C. Wegner Wippel (New Haven, US)

Presentation thumbnail

Six-minute walk distance uncovers high-risk HFrEF patients despite guideline-based assessment

Doctor M. Chudy (Bratislava, SK)

Presentation thumbnail

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Doctor H. Seo (Seoul, KR)

Presentation thumbnail

Prognostic value of soluble ST2 and NT-proBNP in symptomatic patients with heart failure and reduced ejection fraction

Doctor A. Ntalianis (Athens, GR)

Presentation thumbnail

Determinants of recurrent-event model performance in TOPCAT-Americas

Doctor B. Szabo-Soderberg (Stockholm, SE)

Access the full session

Session thumbnail

Progress in predicting prognosis in heart failure?

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources